《異動股》移卡(09923.HK)續漲13% 股價屢創上市新高
憧憬獲納入「港股通」的移卡(09923.HK)八連漲,股價更第五天屢創上市新高,今天急漲13%報76元(即市高位),上市不足兩個半月,股價已較上市價16.64元,累飆3.5倍,成交318萬股,涉資2.34億元。
上市前騰訊(00700.HK)持有3.93%股權的移卡是內地領先以支付為基礎的科技平台,為商戶及消費者提供支付及商業服務。股份於今年6月1日以每股16.64元來港上市,掛牌首一個月股價徘徊於14.92-19.4元之間,7月3日開始發力向上突破。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.